Related Experiment Video
Updated: Jul 11, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline
Rohan Garje1, R Bryan Rumble2, Rahul A Parikh3
1Miami Cancer Institute, Miami, FL.
Summary
ASCO Rapid Recommendation Updates provide timely revisions to cancer care guidelines based on new evidence. These updates ensure healthcare providers and patients have access to the latest cancer treatment options.
Area of Science:
- Oncology
- Clinical Practice Guidelines
- Evidence-Based Medicine
Background:
- Clinical practice guidelines require regular updates to reflect new scientific evidence.
- The American Society of Clinical Oncology (ASCO) develops guidelines to standardize cancer care.
- Practice-changing data necessitates timely dissemination to clinicians.
Purpose of the Study:
- To highlight revisions to existing ASCO guideline recommendations.
- To disseminate updated cancer care information rapidly.
- To inform healthcare practitioners and the public about optimal cancer care.
Main Methods:
- ASCO Rapid Recommendation Updates are based on thorough evidence reviews.
- Updates follow established ASCO guideline development processes.
- Methodology is detailed in the ASCO Guideline Methodology Manual.
Main Results:
- Select ASCO guideline recommendations are revised.
- New and practice-changing data triggers these revisions.
- Updated recommendations are made available to stakeholders.
Conclusions:
- Rapid updates ensure guidelines remain current and relevant.
- Timely dissemination supports informed clinical decision-making.
- Guidelines serve as a resource, not a replacement for clinical judgment.
